The Global DNA Synthesis Industry stands on the threshold of a remarkable ascent, projecting its value to skyrocket from US$ 2,898.3 million in 2023 to an extraordinary US$ 9,999.6 million by 2033. Spearheading this exceptional trajectory is a robust Compound Annual Growth Rate (CAGR) of 13.2%, marking a transformative era for DNA synthesis.
DNA synthesis, a realm encompassing both natural and artificial processes, is undergoing a profound paradigm shift. In the natural domain, the intricate process of nucleic acid strand creation through DNA replication unfolds. Concurrently, laboratories worldwide are embracing the synthetic approach, leveraging the power of genetic engineering and enzyme chemistry to drive groundbreaking advancements across diverse domains. These applications span therapeutics, diagnostics, and academic and industrial research, heralding a new era of innovation.
The industry is witnessing an unprecedented surge in DNA synthesis adoption, positioning itself as a catalyst for revolutionizing scientific research, healthcare, and innovation. As this surge unfolds, the sector is poised to redefine the landscape of discovery, contributing significantly to a brighter and healthier future for humanity.
Request a Sample Report Now to get Premium Insights:
https://www.futuremarketinsights.com/reports/sample/rep-gb-5900
The growing adoption of gene therapy has contributed to the rise in the need for rapid gene synthesis products. These products provide accurate gene sequences in a short period. It enhances the body’s ability to fight against infection and diseases. The utilization of DNA synthesis is increasingly becoming important to avoid any alteration to DNA that may result in oncological diseases. In addition to this, the demand for DNA synthesis is also escalating due to its ability to repair the disease of premature aging.
The synthetic biology segment is a primary growth driver of the DNA synthesis industry and accounts for a major share. Again, growing research and development associated with gene synthesis along with constant advancements made in the technological processes such as molecular separation and protein purification technology which assist in developing reliable, fast, and cost-effective solutions also contribute to the target market growth over the projected period.
“Rising application of DNA synthesis in areas like therapeutic, diagnostics, and academic and industrial research will drive the market growth of the same over the forecast period,” says an FMI analyst.
Key Takeaways:
- Advancements in technological processes will strengthen the future possibilities of the DNA synthesis market.
- Extended wait for approvals of gene synthesizers and products may stunt the market growth.
- North America accounts for 30.2% of the global market share.
- The DNA synthesis industry in Europe will likely hold 27.9% of the overall market share.
Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-5900
Competitive Landscape
Brooks Automation, Inc. (GENEWIZ), Boster Biological Technology, ProteoGenix, Biomatik, ProMab Biotechnologies, Inc, Thermo Fisher Scientific, Inc, Integrated DNA Technologies, Inc, and OriGene Technologies, Inc., among others are some of the major players in the DNA synthesis industry profiled in the full version of the report.
Leading market players are focusing on utilizing innovative marketing plans to achieve the highest profits. These enterprises are also keen on mergers, partnerships, and collaboration to strengthen their market presence.
Key Segments
By Service Type:
- Oligonucleotide DNA Synthesis
- Universal Oligonucleotide DNA Synthesis
- Custom Oligonucleotide DNA Synthesis
- Gene DNA Synthesis
- Custom Gene DNA Synthesis
- Gene Library DNA Synthesis
By Application:
- DNA Synthesis for Research and Development
- DNA Synthesis for Academic Applications
- DNA Synthesis for Industrial Applications
- DNA Synthesis for Diagnosis
- DNA Synthesis for Therapeutics
By End User:
- DNA Synthesis for Biopharmaceutical Companies
- DNA Synthesis for Academic and Research Institutes
- DNA Synthesis for Contract Research Organizations
Level Up Your Market Understanding – Buy Now!
https://www.futuremarketinsights.com/checkout/5900
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
